Author | W. Douglas Evans, PhD

Articles

Marketing Off-Label Uses: Shady Practices Within a Gray Market

August 07, 2009

For pharmaceutical companies, off-label use of a drug represents a substantial “gray market,” to which the company is unable to sell their product directly, yet may be a significant revenue stream. Some drugs have been used more for off-label purposes than for originally approved indications.1